article thumbnail

3 Critical KPIs for Pharmacies in 2024: Boosting Cash Flow

DiversifyRx

Employee actions can significantly impact your success in enhancing your KPIs, making internal communication essential. These expenses encompass salaries, bonuses, taxes, benefits, and insurance for all revenue-generating employees. The post 3 Critical KPIs for Pharmacies in 2024: Boosting Cash Flow first appeared on DiversifyRx.

article thumbnail

FDA approves the first OTC continuous glucose monitor

The Checkup by Singlecare

On March 5, 2024, the U.S. Especially for people who are managing diabetes, the Stelo GCM should be used in communication with a healthcare team. According to DexCom, the Stelo glucose biosensor will be available for purchase online in the summer of 2024. Produced by DexCom, Inc., When will Stelo be available?

FDA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Financial assistance for hearing aids

The Checkup by Singlecare

Financial assistance for hearing aids There are several ways to make hearing aids more affordable, including insurance coverage, nonprofit organizations, and discount programs. Insurance coverage Private health insurance through employers and commercial plans vary in terms of coverage, with only some offering assistance for hearing devices.

article thumbnail

New Year’s Resolutions Trends: What Doctors Resolve To Do

Board Vitals - Pharmacist

With 2024 rapidly approaching, there comes the question of New Year’s Resolutions. Patient Communication Some call it creating “happy patients,” others want to improve “patient experience,” and yet others mention “patient satisfaction.” Are they to be made or ignored?

article thumbnail

Novavax is on thin ice, and the latest update isn’t exactly encouraging

STAT

On 2024 guidance, Merck said it expects sales in the range of $62.7-$64.2 In 2024, as in 2023, the industry’s fate seems inextricable from interest rates. Novavax won’t disclose its revenue until later this month, but its latest communications don’t exactly inspire confidence.

Vaccines 114
article thumbnail

Clinical trials for rare diseases

European Pharmaceutical Review

FDA is expected to provide initial feedback on the data submitted by July 2024, with further data to be collected and analysed over the next two years. When Aidan’s insurance company denied coverage for EXONDYS, the data she captured overturned the denial in 24 hours without engaging in the appeal process.

FDA 52
article thumbnail

Top Performing Drug of 2021 - Trulicity (February Edition)

PharmaShots

A qualifying medication is prescribed by their healthcare provider The patients who have no insurance or have Medicare Part D Patients who are not enrolled in Medicaid, full Low-Income Subsidy, or Veterans (VA) benefits. The patient must-have commercial health insurance to use the savings card. Virgin Islands.